{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T10:58:54Z","timestamp":1775905134135,"version":"3.50.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.clindermatol.2020.08.006","type":"journal-article","created":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T02:34:22Z","timestamp":1597113262000},"page":"695-700","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Rosacea, not just skin deep: Understanding thesystemic disease burden"],"prefix":"10.1016","volume":"39","author":[{"given":"Peyton","family":"Morss-Walton","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean S.","family":"McGee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2020.08.006_bb0005","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0140-6736(05)67402-8","article-title":"IDF Epidemiology Task Force Consensus Group. The metabolic syndrome\u2014a new worldwide definition","volume":"366","author":"Alberti","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.clindermatol.2020.08.006_bb0010","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1684\/ejd.2016.2748","article-title":"The relationship between rosacea and insulin resistance and metabolic syndrome","volume":"26","author":"Akin Belli","year":"2016","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.clindermatol.2020.08.006_bb0015","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jaad.2015.04.028","article-title":"Cardiovascular comorbidities in patients with rosacea: a nationwide case-control study from Taiwan","volume":"73","author":"Hua","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2020.08.006_bb0020","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.jaad.2015.07.009","article-title":"Luz Felipe da Silva D, Kang S, Chien AL. Rosacea is associated with chronic systemic diseases in a skin severity\u2013dependent manner: results of a case-control study","volume":"73","author":"Rainer","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2020.08.006_bb0025","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.jaad.2017.09.016","article-title":"Comorbidities in rosacea: a systematic review and update","volume":"78","author":"Haber","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2020.08.006_bb0030","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/bjd.12838","article-title":"Antihypertensive drugs and the risk of incident rosacea","volume":"171","author":"Spoendlin","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2020.08.006_bb0035","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1111\/jdv.12234","article-title":"Rosacea and cardiovascular risk factors: a case control study","volume":"28","author":"Duman","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2020.08.006_bb0040","article-title":"Noninvasive assessment of subclinical atherosclerosis in patients with rosacea","author":"G\u00fcrel","year":"2019","journal-title":"G Ital Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2020.08.006_bb0045","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.jaad.2017.08.032","article-title":"Obesity and risk for incident rosacea in US women","volume":"77","author":"Li","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2020.08.006_bb0050","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1001\/jamadermatol.2015.2230","article-title":"Genetic vs environmental factors that correlate with rosacea: a cohort-based survey of twins","volume":"151","author":"Aldrich","year":"2015","journal-title":"JAMA Dermatol."},{"key":"10.1016\/j.clindermatol.2020.08.006_bb0055","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1590\/abd1806-4841.20176832","article-title":"Thickness of carotid intima and epicardial fat in rosacea: a cross-sectional study","volume":"92","author":"Belli","year":"2017","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.clindermatol.2020.08.006_bb0060","doi-asserted-by":"crossref","first-page":"705","DOI":"10.2340\/00015555-3167","article-title":"Increased risk of cardiovascular diseases in female rosacea patients: a nested case-control study","volume":"99","author":"Sinikumpu","year":"2019","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.clindermatol.2020.08.006_bb0065","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.jaad.2016.02.1158","article-title":"Assessment of the risk of cardiovascular disease in patients with rosacea","volume":"75","author":"Egeberg","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2020.08.006_bb0070","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s13555-016-0144-3","article-title":"Cardiovascular disease outcomes associated with three major inflammatory dermatologic diseases: a propensity-matched case control study","volume":"6","author":"Marshall","year":"2016","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.clindermatol.2020.08.006_bb0075","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1097\/MIB.0000000000000644","article-title":"Rosacea in patients with ulcerative colitis and Crohn\u02bcs disease: a population-based case-control study","volume":"22","author":"Spoendlin","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.clindermatol.2020.08.006_bb0080","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jaad.2016.08.022","article-title":"Inflammatory bowel disease is associated with an increased risk of inflammatory skin diseases: a population-based cross-sectional study","volume":"76","author":"Kim","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2020.08.006_bb0085","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/bjd.14930","article-title":"Rosacea and gastrointestinal disorders: a population-based cohort study","volume":"176","author":"Egeberg","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2020.08.006_bb0090","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.jaad.2016.11.065","article-title":"Risk of inflammatory bowel disease in patients with rosacea: results from a nationwide cohort study in Taiwan","volume":"76","author":"Wu","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2020.08.006_bb0095","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1136\/gut.32.12.1461","article-title":"Simplified single sample 13Carbon urea breath test for Helicobacter pylori: comparison with histology, culture, and ELISA serology","volume":"32","author":"Logan","year":"1991","journal-title":"Gut"},{"key":"10.1016\/j.clindermatol.2020.08.006_bb0100","first-page":"1603","article-title":"Helicobacter pylori in patients with rosacea","volume":"89","author":"Rebora","year":"1994","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clindermatol.2020.08.006_bb0105","doi-asserted-by":"crossref","first-page":"551","DOI":"10.3346\/jkms.2000.15.5.551","article-title":"Relationship between Helicobacter pylori and rosacea: it may be a myth","volume":"15","author":"Herr","year":"2000","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.clindermatol.2020.08.006_bb0110","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/j.1365-4632.2004.02137.x","article-title":"Plasma reactive oxygen species activity and antioxidant potential levels in rosacea patients: correlation with seropositivity to Helicobacter pylori","volume":"43","author":"Baz","year":"2004","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2020.08.006_bb0115","first-page":"282","article-title":"Rosacea: a cutaneous marker of Helicobacter pylori Infection? Results of a pilot study","volume":"83","author":"Diaz","year":"2003","journal-title":"Acta Dermatovenereol"},{"key":"10.1016\/j.clindermatol.2020.08.006_bb0120","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1046\/j.1468-3083.2002.00497.x","article-title":"The link between Helicobacter pylori infection and rosacea","volume":"16","author":"Szlachcic","year":"2002","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2020.08.006_bb0125","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1177\/2050640614559262","article-title":"Helicobacter pylori infection but not small intestinal bacterial overgrowth may play a pathogenic role in rosacea","volume":"3","author":"Gravina","year":"2015","journal-title":"United Eur Gastroenterol J"},{"key":"10.1016\/j.clindermatol.2020.08.006_bb0130","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1111\/jdv.14352","article-title":"Rosacea is associated with Helicobacter pylori: a systematic review and meta-analysis","volume":"31","author":"J\u00f8rgensen","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2020.08.006_bb0135","doi-asserted-by":"crossref","first-page":"e113","DOI":"10.1016\/j.jaad.2016.01.059","article-title":"The role of small intestinal bacterial overgrowth in rosacea: a 3-year follow-up","volume":"75","author":"Drago","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2020.08.006_bb0140","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.cgh.2008.02.054","article-title":"Small intestinal bacterial overgrowth in rosacea: clinical effectiveness of its eradication","volume":"6","author":"Parodi","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.clindermatol.2020.08.006_bb0145","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.jaad.2012.11.038","article-title":"Rosacea and small intestinal bacterial overgrowth: prevalence and response to rifaximin","volume":"68","author":"Weinstock","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2020.08.006_bb0150","doi-asserted-by":"crossref","first-page":"e321","DOI":"10.1111\/1346-8138.13985","article-title":"Effects of the treatment for small intestine bacterial overgrowth on rosacea","volume":"44","author":"Drago","year":"2017","journal-title":"J Dermatol"},{"key":"10.1016\/j.clindermatol.2020.08.006_bb0155","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.jaad.2016.08.055","article-title":"Prevalence and risk of migraine in patients with rosacea: a population-based cohort study","volume":"76","author":"Egeberg","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2020.08.006_bb0160","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.jaad.2013.03.027","article-title":"Migraine, triptans, and the risk of developing rosacea: a population-based study within the United Kingdom","volume":"69","author":"Spoendlin","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2020.08.006_bb0165","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1177\/0333102417731777","article-title":"The relationship between migraine and rosacea: systematic review and meta-analysis","volume":"38","author":"Christensen","year":"2018","journal-title":"Cephalalgia"},{"key":"10.1016\/j.clindermatol.2020.08.006_bb0170","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1001\/jamaneurol.2016.0022","article-title":"Exploring the association between rosacea and parkinson disease: a Danish nationwide cohort study","volume":"73","author":"Egeberg","year":"2016","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.clindermatol.2020.08.006_bb0175","doi-asserted-by":"crossref","first-page":"e141","DOI":"10.1111\/jdv.14638","article-title":"Rosacea and subsequent diagnosis for Parkinson\u2019s disease: a large, urban, single center, US patient population retrospective study","volume":"32","author":"Mathieu","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2020.08.006_bb0180","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/1346-8138.14705","article-title":"Risk of psychiatric disorders in rosacea: a nationwide, population-based, cohort study in Taiwan","volume":"46","author":"Hung","year":"2019","journal-title":"J Dermatol"},{"key":"10.1016\/j.clindermatol.2020.08.006_bb0185","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1159\/000444082","article-title":"Patients with rosacea have increased risk of depression and anxiety disorders: a Danish nationwide cohort study","volume":"232","author":"Egeberg","year":"2016","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2020.08.006_bb0190","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1080\/13548506.2017.1361540","article-title":"The dermatology life quality index (DLQI) and the hospital anxiety and depression (HADS) in Chinese rosacea patients","volume":"23","author":"Wu","year":"2018","journal-title":"Psychol Health Med"},{"key":"10.1016\/j.clindermatol.2020.08.006_bb0195","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1111\/j.1365-2133.2005.06895.x","article-title":"Comorbidity of rosacea and depression: an analysis of the National Ambulatory Medical Care Survey and National Hospital Ambulatory Care Survey\u2014Outpatient Department data collected by the U.S. National Center for Health Statistics from 1995 to 2002","volume":"153","author":"Gupta","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2020.08.006_bb0200","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1080\/13548506.2013.841968","article-title":"Symptom severity and psychological sequelae in rosacea: results of a survey","volume":"19","author":"B\u00f6hm","year":"2014","journal-title":"Psychol Health Med"},{"key":"10.1016\/j.clindermatol.2020.08.006_bb0205","doi-asserted-by":"crossref","first-page":"488","DOI":"10.2340\/00015555-0716","article-title":"Subjective disease perception and symptoms of depression in relation to healthcare-seeking behaviour in patients with rosacea","volume":"89","author":"Abram","year":"2009","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.clindermatol.2020.08.006_bb0210","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/jdv.13748","article-title":"Feelings of stigmatization in patients with rosacea","volume":"31","author":"Halioua","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2020.08.006_bb0215","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/bjc.2015.217","article-title":"Personal history of rosacea and risk of incident cancer among women in the US","volume":"113","author":"Li","year":"2015","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clindermatol.2020.08.006_bb0220","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.canep.2017.01.006","article-title":"Rosacea and risk of cancer in Denmark","volume":"47","author":"Egeberg","year":"2017","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/j.clindermatol.2020.08.006_bb0225","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1001\/jamadermatol.2015.5549","article-title":"Association of rosacea with risk for glioma in a Danish nationwide cohort study","volume":"152","author":"Egeberg","year":"2016","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.clindermatol.2020.08.006_bb0230","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/1346-8138.14918","article-title":"Potential association between rosacea and cancer: a study in a medical center in southern China","volume":"46","author":"Long","year":"2019","journal-title":"J Dermatol"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X20301619?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X20301619?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:17:57Z","timestamp":1760033877000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X20301619"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S0738081X20301619"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2020.08.006","relation":{},"ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rosacea, not just skin deep: Understanding thesystemic disease burden","name":"articletitle","label":"Article Title"},{"value":"Clinics in Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clindermatol.2020.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}